Abdellatif Eman M, Hamouda Emad H
Department of Clinical Pathology, Alexandria University, Faculty of Medicine, Alexandria, Egypt.
Department of Critical Care Medicine, Alexandria University, Faculty of Medicine, Alexandria, Egypt.
Indian J Crit Care Med. 2024 Dec;28(12):1130-1138. doi: 10.5005/jp-journals-10071-24855. Epub 2024 Nov 30.
Prediction of prognosis in sepsis is an essential research area aiming to improve disease outcomes. In this study, we investigated the role of the C-reactive protein (CRP)/procalcitonin (PCT) ratio as a prognostic tool in sepsis patients.
This prospective observational study was conducted at the intensive care unit (ICU) of Alexandria Main University Hospital in the period from January to June 2024. One hundred and seventy patients with a diagnosis of sepsis were enrolled. Sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation (APACHEII) score and CRP/PCT ratio were calculated on admission (day 1), and as a follow-up on day 3. Patients were subsequently divided into survivor and non-survivor groups, and the data were compared.
The CRP/PCT ratio was significantly lower, on admission and on follow-up, in non-survivor patients than in survivor patients. The ratio median (minimum-maximum) in non-survivors was 4.82 (1.51-23.28) vs 11.23 (1.85-136.7) in survivors on admission, and it was 7.37 (2.27-26.36) in non-survivors vs 11.37 (2.78-110.9) in survivors on day 3. The ratio was significantly lower in patients with septic shock than in non-septic shock patients. The ratio had a significant negative correlation with both SOFA and APACHEII scores. The receiver operating characteristic (ROC) curve showed high accuracy of the day 1 CRP/PCT ratio to predict mortality [area under curve (AUC = 0.835)], which is comparable to the day 1 SOFA score (AUC = 0.878) and higher than the day 1 PCT and day 1 APACHE scores.
Our results suggest a potential role for the CRP/PCT ratio, on admission and on follow-up, as a marker for predicting prognosis in sepsis patients, where low ratio values can predict poor disease outcome.
Abdellatif EM, Hamouda EH. Study of the Role of C-reactive Protein/Procalcitonin Ratio as a Prognostic Tool in ICU Patients with Sepsis: A Prospective Observational Study. Indian J Crit Care Med 2024;28(12):1130-1138.
脓毒症预后的预测是旨在改善疾病结局的重要研究领域。在本研究中,我们调查了C反应蛋白(CRP)/降钙素原(PCT)比值作为脓毒症患者预后工具的作用。
本前瞻性观察性研究于2024年1月至6月在亚历山大主大学医院重症监护病房(ICU)进行。纳入170例脓毒症诊断患者。在入院时(第1天)以及第3天进行随访时,计算序贯器官衰竭评估(SOFA)评分、急性生理与慢性健康状况评估(APACHEII)评分以及CRP/PCT比值。随后将患者分为存活组和非存活组,并对数据进行比较。
在入院时和随访时,非存活患者的CRP/PCT比值显著低于存活患者。入院时,非存活患者的比值中位数(最小值 - 最大值)为4.82(1.51 - 23.28),而存活患者为11.23(1.85 - 136.7);在第3天,非存活患者为7.37(2.27 - 26.36),存活患者为11.37(2.78 - 110.9)。脓毒症休克患者的比值显著低于非脓毒症休克患者。该比值与SOFA和APACHEII评分均呈显著负相关。受试者工作特征(ROC)曲线显示,第1天的CRP/PCT比值预测死亡率具有较高准确性[曲线下面积(AUC = 0.835)],这与第1天的SOFA评分(AUC = 0.878)相当,且高于第1天的PCT和第1天的APACHE评分。
我们的结果表明,入院时和随访时的CRP/PCT比值可能作为预测脓毒症患者预后的标志物,其中低比值可预测不良疾病结局。
Abdellatif EM, Hamouda EH. Study of the Role of C-reactive Protein/Procalcitonin Ratio as a Prognostic Tool in ICU Patients with Sepsis: A Prospective Observational Study. Indian J Crit Care Med 2024;28(12):1130 - 1138.